Previous studies have implied that a transcription factor(s) other than
INTRODUCTION
The PRL gene is expressed in a cell type-specific fashion in pituitary lactotropic cells. The pituitary-specific transcription factor Pit-1 has been show to play an important role in expression by the pituitary of the PRL gene (and also of the genes for GH and TSH), both during development (1) and in the mature organism (2) . The PRL promoter contains multiple binding sites for Pit-1, which have been implicated not only in basal PRL gene expression (3) , but also in kinasemediated hormonal regulation of gene expression of this gene. For example, the most proximal of these Pit-1 binding sites, spanning positions Ϫ66 to Ϫ32 and termed 1P, has been reported to direct a response to a number of external agents, including TRH and Ca 2ϩ (4) , cAMP (2, 5) , and constitutively active forms of G-␣ s (6) and G-␣ q (7) and of two negatively acting G proteins, ␣ i and ␣ o (8) . In addition, a more distal site, termed 3P, has been reported to direct a response to cAMP (9) , while both site 3P (9) and the more distal site 4P (10) have been implicated in the Ras responsiveness of the PRL promoter.
The observation that treatment of GH 3 rat pituitary cells with activators of either protein kinase A or protein kinase C stimulated Pit-1 phosphorylation (11) suggested that Pit-1 phosphorylation might mediate many of the hormonal responses that localize to PRL promoter Pit-1 binding sites. However, reports that a number of these responses do not require Pit-1 phosphorylation (2, 12, 13) implied that factors other than Pit-1 are required for regulation of PRL gene expression directed by binding sites for Pit-1. Indeed, it has been known for some time that two ubiquitously expressed factors can bind to site 1P and activate expression via this site: Oct-1 (14) and thyrotroph embryonic factor (TEF) (15) . However, since protein kinase A (PKA)-mediated phosphorylation of Oct-1 strongly decreases its binding, either to an octamer consensus site (16) or to site 1P (R. Ashton and C. Bancroft, unpublished observations), this protein is unlikely to direct kinase-mediated transcriptional activation. TEF mRNA levels are low in GH cells, and this protein is believed to exert its major action in thyrotroph development and regulation of TSH␤ expression in this pituitary cell type (15) . More recently, a possibly ubiquitous factor has been implicated in a Pit-1-independent transcriptional action of PKA that is mediated by PRL promoter site 1P in nonpituitary cells (5) , but this factor has apparently not yet been further characterized. Finally, the studies described above of Ras responsiveness of the PRL promoter via Pit-1 binding sites (9, 10) have provided evidence that this response involves binding of an Ets-1-like factor within or adjacent to such a site.
To search for factors that might play a role in regulation of PRL gene expression via the proximal Pit-1 binding site 1P, we employed this DNA element as a probe to screen a bacteriophage cDNA expression library prepared from the GC rat pituitary cell line. We report here the identification and characterization of PREB (PRL regulatory element binding), a WD motif transcription factor. PREB binds specifically to PRL promoter site 1P but contains no discernable DNAbinding motif in its sequence; exhibits a nuclear accumulation in pituitary cells; and can both activate PRL promoter activity, alone or in the presence of Pit-1, and transmit the transcriptional action of PKA to this promoter.
We also report evidence that PREB is encoded by a single-copy gene in human and rat, while singlecopy PREB gene homologs are also detected in Drosophila and yeast; and that PREB transcripts accumulate in multiple tissues in human, exhibiting patterns consistent with tissue-specific splicing. We propose that PREB represents a novel type of evolutionarily conserved transcription factor that may contribute to regulation of PRL gene expression in the mammalian pituitary, and that this protein and/or its isomers or analogs may also play a more widespread transcriptional role in various tissues and organisms.
RESULTS

Expression Cloning of PREB
We carried out Southwestern screening, in which a filter-bound, denatured-renatured expression library is screened with a concatenated probe, as described (17, 18) . [ 32 P]-labeled PRL promoter element 1P DNA was employed to screen a GC rat pituitary cell (19) ZAPII cDNA library (Stratagene, La Jolla, CA). Screening of 1.5 ϫ 10 6 plaques yielded several presumptive positive clones that bound to labeled site 1P. However, only one of these clones exhibited DNAsequence specificity: binding to element 1P, but not to either a mutated element 1P or a canonical cAMPresponse element (CRE) (data not shown). The properties of this clone, designated PREB (PRL regulatory element binding) protein, was further investigated. The pBLUESCRIPT vector containing PREB cDNA was excised in vivo, and the cloned cDNA was sequenced, yielding a 1.28-kb sequence containing a large (243-amino acid) open reading frame (Fig. 1 , amino acids 175-417).
PREB Exhibits DNA Sequence-Specific Binding to PRL Promoter Element 1P
Electrophoretic mobility shift was employed to examine the DNA sequence-binding specificity of recombinant PREB(175-417) ( Fig. 2A) . PREB(175-417) plus the element 1P probe that was employed to clone PREB(175-417) yielded a major shifted band, plus weaker lower mol wt bands that probably correspond to partially degraded PREB(175-417) (lane 2), all of which were competed by excess cold element 1P (lanes 3-5). Use of element 1P mutants (illustrated in Fig. 2B ) showed that PREB(175-417) binding to element 1P was also inhibited by an excess of the 1P* mutant (lanes 9-11), but not of the *1P mutant (lanes [6] [7] [8] . The inability of *1P to compete implies that the PREB binding site in element 1P is located at least partially on the 5Ј-side of this element (Fig. 2B) . Since x-ray analysis has recently shown that the Pit-1 POU domain binds to element 1P as a dimer by contacting the bases bracketed in Fig. 2B (20) , the ability of 1P* to compete PREB binding implies that Pit-1 and PREB possess different (but possibly overlapping) binding sites within element 1P. The observation ( Fig. 2A) that PREB(175-417) binding was not competed by excess amounts of oligonucleotides corresponding either to other Pit-1 binding sites, PRL-3P (lanes [12] [13] [14] or GH-GHF1 (lanes [15] [16] [17] , or to two unrelated DNA sequences, an SP1-binding site (lanes [18] [19] [20] or the PRL promoter CLE (CRE-like element) sequence (21) (lanes [21] [22] [23] , further confirms the DNA binding specificity of PREB. Since no known DNA-binding motif can be detected in the PREB(175-417) amino acid sequence shown in Fig. 1 , this specificity is likely to be conferred by a novel DNA-binding motif. At the top is a schematic structure of the protein sequence predicted from the PREB cDNA clone, indicating the motifs identified: three WD repeats plus two PQ-rich regions. Shown below are the nucleotide sequence and the predicted amino acid sequence of PREB. Three sequences exhibiting extensive similarity to the consensus WD motif are underlined, and the P or Q residues in the two PQ-rich regions are circled. In the 3Ј-untranslated region, two ATTTA potential mRNA destabilizing elements and a potential polyadenylation signal are indicated by, respectively, underlining and capital letters. The PREB cDNA sequence has been deposited in the GenBank database under accession no. AF061817.
Isolation of the Full-Length PREB-Coding Sequence
Successive applications of 5Ј-RACE (rapid amplification of DNA ends) to GH 3 cell RNA, employing initially primers corresponding to the 5Ј-terminus of PREB(175-417), yielded an additional 636 bases of 5Ј-terminal DNA sequence, resulting in the PREB cDNA sequence shown in Fig. 1 , containing in-frame methionine codons at positions 1 and 217. The ATG at base 217 is preceded by ACC, matching well the Kozak consensus (ACCAUGG), while the ATG at base 1 is preceded by the poorly matching sequence GGG. The sequence after each methionine encodes PREB containing, respectively, either 345 amino acids (ϳ 38 kDa) or 417 amino acids (ϳ 46 kDa). Putative polyadenylation (AATAAA) and AU-rich mRNA shortened half-life (ATTTA) elements in the cDNA 3Ј-UT are also noted.
Structural Motifs in PREB
Comparison of the PREB cDNA coding sequence with GenBank yielded no match with any previously cloned protein cDNA sequence, implying that PREB is a novel protein. However, portions of the PREB cDNA sequence are similar to several expressed sequence tags of unknown function posted on the Web by the Washington University-Merck EST Project, identified in human infant brain (R12741), and in various mouse tissues: AA111707 (thymus), AA184937 (lymph node), W30204 (19.5-day whole fetus), and AA250620 (tissue not specified).
BLASTN analysis of the PREB sequence revealed three regions (underlined in Fig. 1 ) exhibiting extensive (Ն39%) identity to the WD repeat consensus (␤-transducin motif) (22) (Fig. 3) , identifying PREB as a member of the WD-repeat protein family (23) . The highest degree of similarity between PREB and other known proteins was observed in the PREB region containing WD repeats I and II, which exhibits the following similarity with the corresponding region in two yeast WD- repeat gene regulators: HIR1 (24) (30% identity, 50% similarity), and Tup1 (25) (34% identity, 52% similarity).
PREB also contains two amino acid stretches (residues 86-134 and 223-279) that are unusually rich in both proline and glutamine. Proline-rich and glutamine-rich transactivation motifs have been identified in transcription factors (26) . In addition, protein regions rich in both proline and glutamine have been shown to mediate the transcriptional repression function of the tumor repressor WT1 (27) and to form part of the transcriptional activation domain of YY1 (28) . Either or both of the proline/glutamine-rich domains may thus be responsible for the transactivational capabilities of PREB described below.
PREB Is Encoded by an Evolutionarily Conserved Single-Copy Gene That Is Expressed Both in Rat Pituitary Cells and in Multiple Human Organs
Southern blot analysis with a cDNA probe was employed to investigate the structure and number of PREB genes in various organisms (Fig. 4) . Digestion of rat DNA with EcoRI and HindIII or XhoI and PvuI yielded, upon hybridization with a PREB cDNA probe and hybridization, single or double bands, respectively. The double bands detected with the latter two enzymes probably correspond to cleavage within an intron, since the PREB cDNA sequence contains neither recognition site. Single bands were detected upon hybridization of PREB cDNA to human DNA digested with any of four enzymes. Thus, PREB is apparently a single-copy gene that is well conserved between rat and human. Restriction enzyme digestion of either Drosophila or yeast DNA also yielded either one or two bands that hybridized with rat PREB cDNA, implying that the PREB gene (or a related gene) has been highly conserved during evolution.
We next investigated PREB gene expression, beginning with examination of accumulation of PREB mRNA in the GH 3 rat pituitary cells (Fig. 5 ). Northern analysis of total cellular RNA yielded a single PREB mRNA band comigrating with 18S ribosomal RNA (hence ϳ1.9 kb in size). GH 3 cells thus produce a single predominant molecular form of PREB mRNA, with an apparent size in good agreement with that predicted by the PREB cDNA clone (Fig. 1) . Moreover, it can be seen that Northern analysis of the mRNAs for PREB and Pit-1 mRNA under equivalent conditions of RNA input, probe amounts, and specific activities yielded a PREB mRNA band and a major Pit-1 mRNA band exhibiting comparable intensities. PREB and Pit-1 mRNA thus accumulate to similar levels in the GH 3
Fig. 4. Southern Blot Analysis of the PREB Gene in Various Organisms
DNA isolated from the indicated organisms was digested with the indicated restriction enzymes and subjected to Southern blot analysis, employing a PREB cDNA probe. Hybridization was at reduced stringency (39 C), except for rat DNA, where 42 C was employed. The sizes of internal DNA mol wt markers are indicated.
Fig. 5. Northern Analysis of PREB mRNA in GH 3 Cells
Upper panel, RNA was isolated from GH 3 cells, and two aliquots (15 g) of the same sample were analyzed on the same gel, transferred to nitrocellulose, and hybridized with a cDNA probe for either PREB or Pit-1. To permit comparison of the signals obtained for the two mRNAs, cDNA probes of equal size were labeled to equivalent specific activities, and equal amounts of each probe were employed for hybridization. The positions of the two ribosomal RNA bands are indicated. Lower panel, Stained ribosomal RNAs from the same samples. cells, consistent with an important role for PREB in these cells in regulation of PRL promoter activity.
The isolation from various human and mouse organs of ESTs homologous to PREB mRNA, described above, suggests that the PREB gene may be expressed in multiple tissues. To investigate this question, a human multiple tissue Northern blot was probed with a rat PREB cDNA probe (Fig. 6A) . PREB transcripts were detected in all tissues examined, with the strongest signals seen in heart, skeletal muscle, and pancreas. Significantly, three different bands were detected, corresponding to mRNA sizes of approximately 2.2, 1.9, and 1.5 kb. Most tissues yielded two bands, but different tissues yielded different patterns, suggesting the possibility of tissue-specific alternative splicing of the PREB gene transcript. Thus, all tissues examined except lung yielded the 2.2-kb species (the kidney band is detectable upon prolonged exposure), while the 1.5-kb species was detected only in heart, muscle, and pancreas, and the 1.9-kb species only in brain, placenta, and lung. Finally, lung and liver yielded only, respectively, the 1.9-and 2.2-kb species. The 1.9-kb mRNA band may correspond to the 1.9-kb PREB mRNA species we have detected in the rat GH 3 pituitary cells (see Fig. 5 ).
For the characterization of the regulatory properties of PREB, it was desirable to attempt to identify a PREB-negative cell line, for use both as a negative control for studies of cellular PREB expression and as a recipient for transfection analysis of PREB activity. The widespread distribution of PREB transcripts among human organs suggested that it might be difficult to identify a PREB-negative cell line. However, we have found previously that the rat C6 glial cell line exhibits virtually undetectable expression of transfected PRL promoter constructs in the absence of cotransfected transcription factors (29) , suggesting that this cell line is deficient in factors capable of stimulating PRL promoter activity. Northern analysis of C6 cell polyA ϩ RNA (Fig. 6B ) yielded no detectable PREB mRNA band, under conditions where GH 3 cell mRNA yielded a strong signal for this mRNA; and RT-PCR analysis of C6 cell polyA ϩ RNA (Fig. 6C ) yielded a readily detectable control HGPRT signal, but no detectable PREB signal. In addition, PREB protein was undetectable in the C6 cells, both by Western blot analysis (data not shown) or by immunocytochemistry (see below). Hence, the C6 cells were employed as a PREB-negative cell line in our further studies.
The above observations that PREB transcripts accumulate in a total brain preparation but not in glial cells suggested that PREB expression might be restricted to specific brain regions. To investigate this concept, primers specific for PREB or HGPRT were employed for RT-PCR analysis of cDNA prepared from various human brain tumors (Fig. 6C ). An amplified PREB signal was detected in cDNA prepared from two astrocytomas (lanes 2 and 3) and a metastasis into the brain (lane 6). By contrast, no such signal was detected in cDNA from either of two gliomas (lanes 4 and 5) or from a neuroepithelioma (lane 7), even though an HGPRT signal was detectable in both glioma samples and in the neuroepithelioma sample. These observations with human tumor samples imply that PREB transcripts accumulate in astrocytes but not in glial or neuroepithelial cells, and thus that the PREB gene exhibits region-specific expression within the brain.
PREB Can Function as a Transcriptional Activator
To begin to investigate whether PREB might serve as a pituitary cell transcription factor, we investigated the expression and intracellular location of PREB protein in the GH 3 rat pituitary cells. Nuclear or cytosolic proteins isolated from an equal number of cells were subjected to Western blot analysis (Fig. 7A) . Anti-PREB antiserum, but not control preimmune serum, detected a major approximately 45-kDa band that accumulates preferentially in nuclei. This observation implies that PREB is a nuclear protein in pituitary cells. In addition, the size of the protein detected suggests both that synthesis of this protein is initiated by the more N-terminal methionine encoded by the PREB cDNA sequence (i.e. amino acid 1 in Fig. 1 ) and that the entire PREB cDNA coding sequence has been cloned.
The intracellular location of PREB was examined further by immunocytochemical analysis (Fig. 7B) . With anti-PREB antiserum, the pituitary GH 3 cells yielded a strong signal that was located specifically over the nuclei, while control rat glial C6 cells yielded only a faint diffuse background signal. Preimmune serum also yielded only a background signal with GH 3 cells (Fig. 7B ) or C6 cells (data not shown). The observation with both techniques that PREB crossreacting material exhibits a substantial nuclear accumulation in pituitary cells is consistent with a role for PREB as a cellular transcription factor.
To investigate directly a possible role for PREB as a PRL gene transcription factor, we examined the ability of this protein to transactivate PRL promoter activity in rat glial C6 cells which, as described above, do not exhibit detectable PREB expression. We first examined the ability of PREB to regulate expression of a construct (Ϫ1957)PRL-CAT (chloramphenicol acetyl transferase), which contains the first 1957 bp upstream of the PRL gene body and thus covers both the promoter and enhancer regions (30) (Fig. 8) . As expected from previous studies (29) , this PRL-CAT construct alone was inactive in the C6 cells, but was activated by coexpression of Pit-1. Coexpression of PREB was also observed to activate (Ϫ1957)PRL-CAT expression, showing that this protein can act as a transcriptional activator. Although in the experiment illustrated, PREB was more active than Pit-1, in other similar experiments, the two proteins exhibited equivalent activation of (Ϫ1957)PRL-CAT expression (data not shown). This result demonstrates that PREB can transactivate PRL promoter/enhancer activity. This region of the PRL-regulatory region contains at least seven binding sites for Pit-1 (30) . The similar levels of activity observed for Pit-1 and PREB on this construct thus suggests that the PRL promoter/enhancer region may also contain multiple functional PREB-binding sites. Since element 1P is the only presently known PREB-binding site in the PRL promoter (Fig. 2) , we concentrated on this site in our further functional studies of PREB. To study element 1P in its natural context within the PRL promoter, we investigated the ability of exogenously expressed PREB to transregulate construct (Ϫ113)PRL-CAT. As illustrated in Fig. 9 (top) , the only known PRL promoter elements in this truncated construct are the CLE, element 1P, and a TATA box. The observation that the CLE does not bind PREB (Fig. 2) implies that any effects of PREB (and/or Pit-1) on this PRL-CAT construct are mediated via element 1P.
A comparison of the abilities of various inputs of RSV-based expression vectors for Pit-1 and PREB to transregulate (Ϫ113)PRL-CAT expression (Fig. 9) yielded equivalent stimulation by the two proteins. This result again demonstrates that PREB can act as a transcriptional activator of a PRL promoter-regulatory region. Furthermore, since Pit-1 is known to be a powerful transactivator of PRL gene expression (31, 32) , the observation of equivalent activities for Pit-1 and PREB on two PRL-regulatory region constructs (see Figs. 8 and 9 ) suggests that PREB may also represent a significant regulator of expression of this gene.
The results of electrophoretic shift mobility analysis described above imply that the PREB-and Pit-1-binding sites within element 1P are centered over different regions. We thus investigated the ability of PREB to regulate PRL promoter activity in the presence of Pit-1 (Fig. 10) . As before, transfection of an equal amount (2.5 g) of an expression construct for either protein alone yielded similar levels of transactivation of (Ϫ113)PRL-CAT. Cotransfection of 2.5 g of expression vectors for each protein yielded a level of transactivation that was approximately additive over that yielded by either expression vector alone, suggesting that these two proteins exert additive actions on element 1P. Doubling the input of each expression vector, to close to maximal activity levels (see Fig. 9 ), increased expression approximately 3-fold, again consistent with an approximately additive action of PREB and Pit-1. These observations suggest that, at least in the basal cellular state, these two proteins may exert actions on element 1P that are of approximately equal strength, but are largely independent. C6 rat glial cells (2.6 ϫ 10 6 ) were electroporated with (Ϫ1957)PRL-CAT (10 g) plus RSV-␤ gal (2 g), plus 5 g either RcRSV ("None"), or RSV-Pit-1 or RSV-PREB, divided into three 60-mm dishes, incubated 2 days, and then assayed for CAT and ␤-galactosidase activity. Shown is the mean Ϯ SD of CAT activity, corrected for ␤-galactosidase activity, observed with triplicate dishes. Top, Structure of plasmid (Ϫ113)PRL-CAT, illustrating the positions of the known PRL promoter elements. Bottom, C6 cells (2.6 ϫ 10 6 ) were electroporated with (Ϫ113)PRL-CAT (10 g) and RSV-␤ gal (2 g), plus the indicated amounts of either RSV-Pit-1 or RSV-PREB, and treated thereafter as in Fig. 8 . Shown is the mean Ϯ SD of corrected CAT activity observed with triplicate dishes. Fig. 9 , plus the indicated amounts of RSV-PREB and/or RSV-Pit-1 ("1" ϭ 2.5 g plasmid), and treated thereafter as in Fig. 8 . Shown is the mean Ϯ SD of corrected CAT activity observed with triplicate dishes.
PREB Can Mediate Transcriptional Stimulation by PKA in Either GH 3 Pituitary Cells or Heterologous C6 Cells
As described above, previous studies have implied that Pit-1 is not the direct functional target of PKA action on the PRL promoter. Inspection of the predicted PREB amino acid sequence revealed a number of potential PKA phosphorylation sites (data not shown). This, together with the observations described above that PREB can bind specifically to PRL element 1P and exhibits transcriptional activity, suggested that PREB may represent the cellular protein that directly mediates PKA action on the PRL promoter via element 1P. To begin to investigate this possibility in GH 3 cells, under conditions that are independent of both endogenous PREB and PREB-binding sites, we investigated the ability of a GAL4-PREB fusion protein to transmit PKA action to a cotransfected GAL4 indicator construct (Fig. 11) . As expected, control GAL (1-147) was unable to transactivate 5XGAL4-CAT expression, in either the presence or absence of an RSV-PKA expression vector. In the absence of RSV-PKA, GAL4-PREB alone strongly transactivated 5XGAL4-CAT, demonstrating again that PREB contains a transcriptional activator domain. Cotransfection of RSV-PKA yielded an approximately 3-fold increase in the ability of GAL4-PREB to transactivate 5XGAL4-CAT. This observation demonstrates that PREB can support a PKA-mediated transcriptional response in pituitary cells, possibly in the absence of any change in its ability to bind DNA.
We next investigated whether PREB can transmit a PKA transcriptional signal to the PRL promoter, in the absence of other pituitary cell signals. To do this, we examined the effect of expression of RSV-PKA in C6 glial cells on transactivation by either Pit-1 or PREB of indicator construct (Ϫ113)PRL-CAT (Fig. 12) . As before, (Ϫ113)PRL-CAT alone exhibited minimal activity, which was only slightly increased by coexpression of PKA. Coexpression of Pit-1 strongly transactivated CAT activity. However, this activity was not further increased by coexpression of PKA, in agreement with previous observations (2) . In contrast, the transactivation of CAT activity by PREB was strongly increased by coexpression of PKA. Thus, PREB (but not Pit-1) can support a PKA-mediated transcriptional response directed by element 1P in the context of the PRL promoter.
DISCUSSION
We report here the identification of an 1805-bp rat cDNA encoding a 417-amino acid protein, PREB. This protein binds directly to a regulatory element in the PRL promoter, element 1P, previously shown to represent a target for the pituitary-specific transcription factor Pit-1, and can mediate both basal and PKAactivated expression of the PRL promoter.
Analysis of the primary sequence of PREB revealed that it is a novel protein. However, PREB contains three segments (Fig. 3, WD I , WD II, and WD III) possessing a significant degree of homology to the WD repeat consensus and is thus identified as a member of the WD-repeat protein family (23) . It is interesting that the highest degree of similarity between PREB and known proteins occurs in segments WD I and WD II, which resemble regions in the two yeast WD-repeat gene regulators, HIR1 (24) and Tup1 (25) . Two significant features are shared by most known members of the subset of WD-repeat proteins that are gene regulators [HIR1 and Tup1, plus the Drosophila proteins Groucho (33) and dTAF II 80 (34) , yeast Met30p (35) , and plant COP1 (36)]: 1) Of the proteins whose regulatory functions are known (all but dTAF II 80), each is a repressor of its target gene. 2) With one possible exception, none is a DNA-binding protein; instead they all repress their target genes by interacting with a DNA-bound transcription factor. The possible exception is COP1, which may bind directly to DNA via a novel zinc-binding motif (36) . The first common feature above suggests that PREB might prove, under some conditions, to represent a repressor of target gene expression. The second common feature implies that PREB may represent the first member of a new family of mammalian WD-repeat gene regulatory transcription factors that act by binding directly to a DNA target.
PREB(175-417) exhibited DNA sequence-specific binding to site 1P. However, the amino acid sequence of this portion of PREB exhibits no homology to known DNA-binding motifs, implying that this region of PREB will prove to contain a DNA-binding region(s) representing a novel member of this class of regulatory domains. Analysis by electrophoretic mobility shift assay of interaction of PREB(175-417) with site 1P mutants (Fig. 3) implied that at least a portion of the PREB-binding site resides upstream of the well defined binding site for Pit-1 in this element (20) . This observation suggests the possibility that PREB and Pit-1 can co-occupy element 1P, which could represent the structural basis for the ability of PREB and Pit-1 to exhibit additive activity on the PRL promoter via this element (see below).
A number of observations suggest that PREB plays a role as a pituitary cell transcription factor. Antiserum raised against recombinant PREB detects a major protein that localizes to the nuclei of GH 3 cells (Fig. 7) . It is conceivable that the protein detected corresponds to a cross-reacting protein. However, the observation that the apparent size of the detected protein, 45 kDa, corresponds to that predicted for PREB, and that PREB mRNA is expressed in GH 3 cells (Fig. 5) , strongly suggests that this protein represents endogenous PREB, and that PREB is thus a nuclear protein in pituitary cells. The observation that PREB exhibits sequence-specific binding to a specific element in the PRL promoter (Fig. 3) suggested that PREB might be capable of regulating transcription of this promoter. The ability of PREB to stimulate PRL promoter activity was demonstrated directly by the observation that this protein can stimulate activity of cotransfected PRL-CAT constructs in heterologous cells (Figs. 8-10 and  12 ). In these investigations, PREB yielded transactivation of a truncated PRL promoter that was equivalent to that yielded by Pit-1. The interexperimental variability in the relative basal transactivation activities of the two proteins on either the full-length PRL promoter/ enhancer region (see Results text) or on this truncated promoter (e.g. compare Figs. 9 and 10 with Fig. 12 ) does not permit a more precise delineation of the relative activities of PREB and Pit-1 on PRL promoter activity. However, the observation that the two proteins exhibited approximately additive transactivational activities on the truncated PRL promoter (Fig.  10) is consistent with the concept that PREB can strongly regulate basal PRL promoter activity independently of Pit-1. Although these experiments, together with the transactivational properties of a GAL4-PREB fusion (Fig. 11) , clearly imply that PREB can act as a transcriptional activator, it is not presently known which region of the protein is responsible for transactivation. However, as noted above, it seems possible that such a domain may encompass either or both of the PREB proline/glutamine-rich regions between residues 86-134 and 223-279. The observation that a region containing this type of motif has been shown previously to mediate the ability of the tumor repressor WT1 to repress transcription (27) suggests the interesting possibility that PREB may, in the appropriate context, act as a transcriptional repressor.
What might be the physiological role of PREB in pituitary cells? The ability of PREB to transactivate cotransfected PRL constructs in heterologous cells suggests a role for this protein in basal PRL gene expression. Similarly, the ability of PREB (Fig. 12) , but not Pit-1 ( Fig. 12 ; see also Refs. 2 and 12), to mediate PKA stimulation of a cotransfected PRL-CAT construct in heterologous cells suggests that PREB may play a role in cAMP-mediated transcriptional actions of extracellular stimulators of PRL promoter activity such as PACAP, which is apparently completely dependent upon cellular PKA activity for its transcriptional activation of the PRL promoter (21) . The ability of a PREB fusion protein to direct either basal or PKAstimulated transcriptional effects to a heterologous target promoter in a pituitary cell context (Fig. 11) lends further support to this suggestion. However, it should be emphasized that a determination of whether PREB does play a significant physiological role in either basal or PKA-stimulated regulation of PRL gene expression will require further investigations, involving examination of the consequences of repression of PREB activity in pituitary cells.
The present studies imply that PREB has the capacity to mediate PKA action on the PRL promoter in the absence of Pit-1 (Fig. 12) . This property and the observations that PREB exhibits sequence-specific binding to element 1P (Fig. 2) and that its mRNA sequences are expressed in multiple tissues (Fig. 6) are consistent with the functional properties of a factor detected by Gutierrez-Hartmann and co-workers (5) in HeLa cells, which has been reported to exhibit Pit-1-independent regulation of the PRL promoter via element 1P. Although the HeLa cell factor has apparently not yet been further characterized, it is thus possible that PREB corresponds to this factor. The studies to date of both PREB and the HeLa cell factor imply that PKA-mediated regulation of PRL promoter activity can occur in the absence of Pit-1. However, it seems possible that, although Pit-1 alone cannot mediate PKA transcriptional actions, an interaction between Pit-1 and PREB on PRL promoter element site 1P could yield an enhanced response by pituitary cells to PKAmediated stimuli. A possible model for this type of cellular role for PREB would involve PREB activation via PKA-mediated phosphorylation. Although it is not yet known whether PREB can serve as a PKA substrate either in vitro or in vivo, the predicted sequence of this protein (Fig. 1) does contain a number of sequences resembling PKA phosphorylation consensus sites (37) . Finally, a very recent report that the cofactor CBP (CREB-binding protein) can interact with Pit-1 during a PKA-mediated transcriptional response (38) suggests the interesting possibility of an anologous functional interaction between CBP and PREB.
A number of observations suggest that PREB may also play a transcriptional role in organs other than the pituitary. The observation that a GAL4-PREB construct can transmit both basal and PKA-stimulated transcriptional effects to a GAL4 promoter construct (Fig. 11) implies that PREB can exert these actions independently of its ability to bind to the PRL promoter. Consistent with a wider role for this protein, PREB transcripts were observed in all human tissues examined (Fig. 6A) . It is of course conceivable that some of the PREB transcript size variants detected in specific tissues in this experiment arise from modifications in either transcript initiation site or poly(A) tail size. However, the tissue-specific transcript size patterns observed does suggest the possibility of alternative splicing of the initial PREB transcript, and thus of the production in different tissues of isoforms of PREB potentially possessing unique transcriptional properties. It is worth noting in this connection that the PREB cDNA sequence (Fig. 1) contains a 306-bp (102-amino acid) open reading frame that starts at position 1333 and thus slightly overlaps the terminus of the major PREB open reading frame, suggesting that domain shuffling arising from alternative splicing might generate a PREB isoform containing some or all of this peptide sequence at its N terminus. Finally, the detection of PREB transcripts in human brain tumors arising from astrocytes, but not from glial or neuroepithelial cells (Fig. 6C) , suggests that the PREB gene exhibits region-specific brain expression, and thus the intriguing possibility that PREB serves a specific transcriptional function within restricted portions of the brain.
In summary, we have cloned from a pituitary cell cDNA library a transcription factor, termed PREB, that can bind to a regulatory element in the PRL promoter, and has the capacity to mediate both basal and PKAstimulated activity, either of the PRL promoter, or as a fusion protein of a heterologous promoter. Further investigations should delineate the regions of PREB that direct binding to, and transcriptional activation of, the PRL promoter and also illuminate the physiological role of this novel transcription factor, both within the pituitary and in other tissues that express the PREB gene transcript.
MATERIALS AND METHODS
Imaging of Gels
Autoradiograms of gel blots or photographs of gels were recorded electronically using an AGFA (ARCUS II) Scanner (Agfa-Gevaert Group, Mortsel, Belgium).
Electrophoretic Mobility Shift Assay
Partially purified recombinant his-tagged PREB (PREB amino acids 175-417, preceded by six histidines) was prepared from Escherichia coli by solubilization of an insoluble pellet in binding buffer [5 mM imidazole, 0.8 M NaCl, 10 mM Tris (pH 7.9), 8 M urea], application to a nickel affinity column, gradual refolding in the column by progressive dilution of the urea as described (17) , elution in buffer containing 0.5-1 M imidazole, followed by desalting and concentration in an Amicon (Beverly, MA) spin column. We have previously described the sequences of double-stranded oligonucleotides corresponding to PRL promoter sites 1P, *1P, 1P*, and 3P (39) and the CLE (29) . The sequence of the double-stranded SP1-binding site oligonucleotide probe (containing a 5Ј SalI site) is 5Ј-TCGACGGGGCGGGGCC-3Ј, and of the double-stranded rat GH pGHF-1 site is 5Ј-TCGACTGGCTCCAGCCATGAATA-AATGTATAGGGAAAG-3Ј. All procedures were performed at 4 C in the presence of protease inhibitors [1 mM phenylmethylsulfonyl fluoride (PMSF), 1 g/ml aprotonin, and 5 g/ml leupeptin]. The partially purified his-tagged PREB was then incubated 10 min at room temperature in 9 l containing 10 mM Tris (pH 7.9), 60 mM KCl, 1 mM EDTA, 0.03% NP40, 4% Ficoll, 1 mM dithiothreitol, 5 g poly(dI-dC), 1 g BSA, with or without unlabeled DNA competitors, and then an additional 10 min after addition of 1 ng 32 P-end-labeled site 1P probe, followed by analysis on a 5% polyacrylamide gel in 0.25ϫ Tris-borate-EDTA (TBE) at 4 C. The dried gel was then autoradiographed 1-3 h at Ϫ70 C with intensifying screens.
Cell Lines
GH 3 rat pituitary cells (19) were propagated in suspension culture as described (40) . C6 rat glial cells (41) were maintained in monolayer culture in DMEM containing 5% FCS, 100 mg/ml streptomycin, and 100 U/ml penicillin at 37 C in 10% CO 2 , and cultures were split 1:5 every other day.
Southern Blot Analysis
Standard procedures were employed to prepare genomic DNA from rat GH 3 cells and from Drosophila (provided by Dr. M. Frasch of Mount Sinai). Human DNA was provided by Dr. D. Bishop (Mount Sinai School of Medicine). Yeast genomic DNA was prepared employing a PureGene kit obtained from GENTRA (Minneapolis, MN). Southern blot analysis was performed as described previously (42) , employing a 32 P-labeled probe prepared by either PCR or random primer labeling from a PREB cDNA template, followed by autoradiography for 3-16 h as described above.
Northern Blot and PCR Analysis
Total or poly(A)-enriched RNA was prepared from the GH 3 or C6 cell lines using the Oligotex column affinity purification system (Qiagen, Inc., Chatsworth, CA) without or with addition of oligo-d(T)-linked beads. For Northern analysis, RNA was analyzed by 1% formaldehyde agarose gel electrophoresis as described (43) . After transfer of size-separated RNA to nitrocellulose, baking, and prehybridization (42), the nitrocellulose was hybridized for 15 h to a 32 P-labeled PREB cDNA probe prepared as described above, and the membranes were then autoradiographed for 1-3 days as described above. For PCR analysis of RNA samples, RNA was denatured (70 C, 5 min), annealed with oligo(dT), and subjected to first-strand synthesis in the presence of 100 U reverse transcriptase (SuperSCRIPT II), according to the directions of the manufacturer (Life Technologies, Inc., Gaithersburg, MD). The resultant cDNA, or cDNA prepared from tumor sample RNA, was then subjected to nested PCR using Taq 
Preparation of anti-PREB Antiserum
Inclusion bodies were prepared from E. coli expressing recombinant his-tagged PREB (PREB amino acids 175-417, preceded by six histidines), as described (43) . Briefly, cells were lysed with lysozyme and deoxycholic acid in the presence of 50 mM PMSF, treated with DNAase (1 mg/ml) at room temperature 15-30 min, and subjected to centrifugation. The pellet was then suspended, washed with 6.5 M urea in 0.1 mM Tris, pH 8.5, after which PREB was extracted with elution buffer (8 M urea, 50 mM Tris, pH 8.0, 1 mM EDTA, 100 mM NaCl, 0.1 mM PMSF), and subjected to SDS-PAGE. A gel fragment containing the major PREB band was excised, frozen, ground with a mortar and pestle, and supplied frozen to Cocalico Biologicals, Inc. (Reamstown, PA) for preparation of antiserum in rabbits according to their standard protocol. Before use in Western blots and immunocytochemistry, either anti-PREB antiserum or preimmune serum from the same animal was preadsorbed with extracts of host E. coli. An equal volume of 2ϫ SDS sample buffer was added to a pelleted 50-ml bacterial culture, mixed thoroughly, incubated at 65-70 C for 10 min, fractionated on a 4.5% SDS-PAGE minigel employing a 1.5-mm preparative comb, and transferred to nitrocellulose. After soaking the filter in a 5% solution of Carnation brand nonfat milk, the filter was incubated on a rocking platform either 1 h at room temperature or 4 C overnight, with anti-PREB antiserum diluted 1:250 into TBST buffer (20 mM Tris, pH 7.6; 137 mM NaCl, 0.1% Tween-20) containing 3% BSA, and the adsorbed antiserum was employed for analysis of PREB.
Western Blot Analysis of Cellular Fractions
Nuclei and cytosol (i.e. the soluble fraction of the postnuclear supernatant) were prepared from GH 3 cells as described (44) , in the presence of the protease cocktail described above. Preliminary SDS-PAGE analysis revealed no gross degradation of proteins in either fraction (data not shown), and that, on a per cell basis, the cytosol contained a considerably higher protein content than the nucleus. Samples were subjected to SDS-PAGE, transferred to nitrocellulose on a semidry transfer apparatus (Hoeffer Scientific Instruments, San Francisco. CA), employing Towbin buffer (25 mM Tris, 192 mM glycine, 0.0372% SDS, 20% methanol) for 30-60 min at 100 mA. Filters were blocked for 1 h with 5% Carnation nonfat dry milk in TBST, incubated with anti-PREB antibody (1:250), followed by washing with TBST. The filter was then exposed to secondary antibody (conjugated to horseradish peroxidase and diluted 1:5000) in TBST containing 3% BSA for 30-60 min. After washing with TBST (four times for 10 min each time), immunoreactive proteins were visualized by enhanced chemiluminescence according to the directions of the manufacturer (Amersham Corp., Arlington Heights, IL).
Immunocytochemistry of Cultured Cells
Cells were plated on glass coverslips in serum-containing media the night before use (C6 cells, DMEM plus 5% FCS; GH 3 cells in Ham's F10 plus 15% horse serum plus 2.5% FCS). For use with GH 3 cells, the coverslips were first coated with CellTak (14 g/25 mm coverslip) (Collaborative Biomedical Products, Bedford, MA). The cells were washed twice with PBS, fixed 20 min at room temperature in 2% paraformaldehyde, incubated 20 min in blocking buffer (0.6% Tween 20 in DMEM containing 5% FCS) and then incubated overnight at 4 C with either 1:250 dilutions of preimmune serum or anti-PREB, each preadsorbed as described above. The dishes were then washed three times with PBS and incubated 30 min with rhodamine-labeled goat antirabbit IgG (American Qualex, LaMiranda, CA) at 1:500 in blocking buffer, rinsed three times, and mounted in Mowiol. Images were captured using a 40ϫ oil objective on a Nikon (Melville, NY) inverted microscope with a Cohu (San Diego, CA) CCD4910 camera in conjunction with a Colorado video integrator unit. Digital data were processed with Metamorph software from Universal Imaging (Media, PA).
Plasmids
We have previously described construction of plasmids (Ϫ1957)PRL-CAT and (Ϫ113)PRL-CAT (45, 46) . RSV-PKA was prepared by employing PCR primers to amplify the murine PKA catalytic subunit described by Uhler and McKnight (47) , followed by HindIII/Xba digestion of the amplified product, and ligation into the corresponding site in plasmid RcRSV (Invitrogen, San Diego, CA). RSV-Pit-1 (32) and RSV-␤ gal were kindly supplied by Dr. H. Samuels (New York University). GAL4 constructs pSG424 (48) [referred to in the present paper as pGAL4(1-147)] and 5XGAL4-CAT (49) were kindly supplied by Dr. M. Ptashne (Sloan-Kettering Institute). GAL4-PREB was constructed by cloning the PREB coding sequence (amino acids 1-417) upstream of and in register with the GAL4(1-147) sequence in pSG424. RSV-PREB was constructed by cloning the PREB-coding sequence into the HindIII/XbaI site of RcRSV.
Transient Cotransfection Assays
For each treatment group, approximately 0.5 ϫ 10 8 GH 3 cells or 2 ϫ 10 6 C6 cells were subjected to electroporation. Preliminary experiments were performed with PRL-CAT constructs and a known PRL promoter regulator, Pit-1, to optimize transfection efficiency for each cell line (data not shown). For transfection, cells were resuspended in 0.75 ml DMEM containing 10% FBS plus the indicated plasmids and subjected to electroporation at 960 Farads and either 300 V (C6 cells) or 240 V (GH 3 cells), divided among three 60-mm tissue culture dishes, and incubated 48 h as described above for each cell line. One day after transfection, each dish was examined microscopically, and any experiment that exhibited gross differences in cell survival among different treatment groups was discarded. Cells were then harvested with a rubber policeman, lysed by sonication (four times for 2 min each time) in 0.25 M Tris, pH 7.8, 10 mM EDTA, and heated 65 C for 10 min to inactivate deacetylases. Half of each cell extract was assayed for CAT activity as described previously (12) , employing [ 3 H]chloramphenicol (0.01 Ci/l) and butyryl CoA (5 mg/ml) and a 4-h incubation, which yielded results in the linear range of the assay. The remainder of the cell extract was employed for assay of ␤-galactosidase activity as described (42) . For each experimental condition, the average CAT assay result was divided by the average ␤-galactosidase activity under that condition, relative to a value of 1 assigned to the average ␤-galactosidase activity in the controls. It may be noted that this procedure always yielded a correction of Յ2%. Each experiment reported here has been repeated a total of at least three times, with results similar to those shown in the figures.
